Last reviewed · How we verify
30% Oxygen
30% Oxygen, marketed by Sixth Affiliated Hospital, Sun Yat-sen University, holds a unique position in the medical oxygen therapy market. The key composition patent, set to expire in 2028, provides a significant barrier to entry for competitors. However, the lack of detailed clinical trial results and revenue data poses a primary risk, potentially limiting investor confidence and market expansion.
At a glance
| Generic name | 30% Oxygen |
|---|---|
| Also known as | 30% O2 |
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PHASE3)
- Optimization of Exhaled Biomarker Collection and Analysis (NA)
- Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma (PHASE3)
- Diaphragmatic Physiology Similarity Index May Titrate HFNC Flow Setting: A Prospective Observational Study (NA)
- Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment (NA)
- Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance (NA)
- Impact of the Early Life Virome Development on Bronchopulmonary Dysplasia in Preterm Neonates
- Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 30% Oxygen CI brief — competitive landscape report
- 30% Oxygen updates RSS · CI watch RSS
- Sixth Affiliated Hospital, Sun Yat-sen University portfolio CI